Cargando…
Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients
An important checkpoint in the progression of melanoma is the metastasis to lymph nodes. Here, to investigate the role of lymph node NK cells in disease progression, we analyze frequency, phenotype and functions of NK cells from tumor-infiltrated (TILN) and tumor-free ipsilateral lymph nodes (TFLN)...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338526/ https://www.ncbi.nlm.nih.gov/pubmed/25472612 http://dx.doi.org/10.1038/ncomms6639 |
_version_ | 1782481229683097600 |
---|---|
author | Ali, Talib Hassan Pisanti, Simona Ciaglia, Elena Mortarini, Roberta Anichini, Andrea Garofalo, Cinzia Tallerico, Rossana Santinami, Mario Gulletta, Elio Ietto, Caterina Galgani, Mario Matarese, Giuseppe Bifulco, Maurizio Ferrone, Soldano Colucci, Francesco Moretta, Alessandro Kärre, Klas Carbone, Ennio |
author_facet | Ali, Talib Hassan Pisanti, Simona Ciaglia, Elena Mortarini, Roberta Anichini, Andrea Garofalo, Cinzia Tallerico, Rossana Santinami, Mario Gulletta, Elio Ietto, Caterina Galgani, Mario Matarese, Giuseppe Bifulco, Maurizio Ferrone, Soldano Colucci, Francesco Moretta, Alessandro Kärre, Klas Carbone, Ennio |
author_sort | Ali, Talib Hassan |
collection | PubMed |
description | An important checkpoint in the progression of melanoma is the metastasis to lymph nodes. Here, to investigate the role of lymph node NK cells in disease progression, we analyze frequency, phenotype and functions of NK cells from tumor-infiltrated (TILN) and tumor-free ipsilateral lymph nodes (TFLN) of the same patients. We show an expansion of CD56(dim)CD57(dim)CD69+CCR7+KIR+ NK cells in TILN. TILN NK cells display robust cytotoxic activity against autologous melanoma cells. In the blood of metastatic melanoma patients the frequency of NK cells expressing the receptors for CXCL8 receptor is increased compared to healthy subjects, and blood NK cells also express the receptors for CCL2 and IL6. These factors are produced in high amount in TILN and in vitro switch the phenotype of blood NK cells from healthy donors to the phenotype associated with TILN. Our data suggest that the microenvironment of TILN generates and/or recruits a particularly effective NK cell subset. |
format | Online Article Text |
id | pubmed-4338526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-43385262015-06-04 Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients Ali, Talib Hassan Pisanti, Simona Ciaglia, Elena Mortarini, Roberta Anichini, Andrea Garofalo, Cinzia Tallerico, Rossana Santinami, Mario Gulletta, Elio Ietto, Caterina Galgani, Mario Matarese, Giuseppe Bifulco, Maurizio Ferrone, Soldano Colucci, Francesco Moretta, Alessandro Kärre, Klas Carbone, Ennio Nat Commun Article An important checkpoint in the progression of melanoma is the metastasis to lymph nodes. Here, to investigate the role of lymph node NK cells in disease progression, we analyze frequency, phenotype and functions of NK cells from tumor-infiltrated (TILN) and tumor-free ipsilateral lymph nodes (TFLN) of the same patients. We show an expansion of CD56(dim)CD57(dim)CD69+CCR7+KIR+ NK cells in TILN. TILN NK cells display robust cytotoxic activity against autologous melanoma cells. In the blood of metastatic melanoma patients the frequency of NK cells expressing the receptors for CXCL8 receptor is increased compared to healthy subjects, and blood NK cells also express the receptors for CCL2 and IL6. These factors are produced in high amount in TILN and in vitro switch the phenotype of blood NK cells from healthy donors to the phenotype associated with TILN. Our data suggest that the microenvironment of TILN generates and/or recruits a particularly effective NK cell subset. 2014-12-04 /pmc/articles/PMC4338526/ /pubmed/25472612 http://dx.doi.org/10.1038/ncomms6639 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Ali, Talib Hassan Pisanti, Simona Ciaglia, Elena Mortarini, Roberta Anichini, Andrea Garofalo, Cinzia Tallerico, Rossana Santinami, Mario Gulletta, Elio Ietto, Caterina Galgani, Mario Matarese, Giuseppe Bifulco, Maurizio Ferrone, Soldano Colucci, Francesco Moretta, Alessandro Kärre, Klas Carbone, Ennio Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title | Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title_full | Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title_fullStr | Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title_full_unstemmed | Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title_short | Enrichment of CD56(dim)KIR+CD57+ highly cytotoxic NK cells in tumor infiltrated lymph nodes of melanoma patients |
title_sort | enrichment of cd56(dim)kir+cd57+ highly cytotoxic nk cells in tumor infiltrated lymph nodes of melanoma patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338526/ https://www.ncbi.nlm.nih.gov/pubmed/25472612 http://dx.doi.org/10.1038/ncomms6639 |
work_keys_str_mv | AT alitalibhassan enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT pisantisimona enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT ciagliaelena enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT mortariniroberta enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT anichiniandrea enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT garofalocinzia enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT tallericorossana enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT santinamimario enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT gullettaelio enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT iettocaterina enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT galganimario enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT mataresegiuseppe enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT bifulcomaurizio enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT ferronesoldano enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT coluccifrancesco enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT morettaalessandro enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT karreklas enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients AT carboneennio enrichmentofcd56dimkircd57highlycytotoxicnkcellsintumorinfiltratedlymphnodesofmelanomapatients |